Johnson & Johnson (NYSE:JNJ) Shares Sold by Financial Engines Advisors L.L.C.

Key Points

• Financial Engines Advisors L.L.C. reduced its holdings in Johnson & Johnson by 15.3%, owning 9,035 shares after selling 1,631 shares in the 1st quarter.
• Johnson & Johnson's recent earnings report revealed an EPS of $2.77, exceeding estimates, with a quarterly revenue of $23.74 billion, representing a 5.8% increase from the previous year.
• The company announced a quarterly dividend of $1.30, scheduled for payout on September 9th, resulting in an annualized dividend yield of 3.0%.

Financial Engines Advisors L.L.C. lessened its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 15.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,035 shares of the company's stock after selling 1,631 shares during the quarter. Financial Engines Advisors L.L.C.'s holdings in Johnson & Johnson were worth $1,498,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in JNJ. Brighton Jones LLC boosted its stake in shares of Johnson & Johnson by 13.9% during the 4th quarter. Brighton Jones LLC now owns 51,876 shares of the company's stock worth $7,502,000 after acquiring an additional 6,332 shares during the last quarter. Hudson Value Partners LLC increased its holdings in Johnson & Johnson by 2.5% in the 4th quarter. Hudson Value Partners LLC now owns 41,403 shares of the company's stock valued at $5,648,000 after acquiring an additional 1,022 shares during the last quarter. Cohen & Steers Inc. increased its holdings in Johnson & Johnson by 5.3% in the 4th quarter. Cohen & Steers Inc. now owns 2,472 shares of the company's stock valued at $358,000 after acquiring an additional 125 shares during the last quarter. Mariner LLC increased its holdings in Johnson & Johnson by 2.4% in the 4th quarter. Mariner LLC now owns 1,615,121 shares of the company's stock valued at $233,566,000 after acquiring an additional 38,169 shares during the last quarter. Finally, CreativeOne Wealth LLC increased its holdings in Johnson & Johnson by 69.1% in the 4th quarter. CreativeOne Wealth LLC now owns 28,241 shares of the company's stock valued at $4,084,000 after acquiring an additional 11,541 shares during the last quarter. Hedge funds and other institutional investors own 69.55% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Guggenheim restated a "neutral" rating and issued a $167.00 target price (up from $164.00) on shares of Johnson & Johnson in a report on Thursday, July 17th. UBS Group lifted their price target on shares of Johnson & Johnson from $180.00 to $190.00 and gave the stock a "buy" rating in a research note on Thursday, July 17th. Benchmark upgraded shares of Johnson & Johnson to a "strong-buy" rating in a report on Thursday, April 24th. Sanford C. Bernstein reiterated a "market perform" rating on shares of Johnson & Johnson in a report on Wednesday, April 16th. Finally, Piper Sandler reiterated an "overweight" rating on shares of Johnson & Johnson in a report on Thursday, July 17th. Nine investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $174.50.

Johnson & Johnson Stock Performance

Shares of NYSE JNJ traded up $0.54 during midday trading on Thursday, reaching $174.96. The company had a trading volume of 8,229,533 shares, compared to its average volume of 9,026,526. The business's 50-day simple moving average is $160.42 and its 200 day simple moving average is $158.01. The stock has a market cap of $421.37 billion, a P/E ratio of 18.71, a P/E/G ratio of 2.20 and a beta of 0.41. Johnson & Johnson has a 1 year low of $140.68 and a 1 year high of $175.72. The company has a current ratio of 1.01, a quick ratio of 0.76 and a debt-to-equity ratio of 0.50.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings results on Wednesday, July 16th. The company reported $2.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.68 by $0.09. The business had revenue of $23.74 billion during the quarter, compared to analysts' expectations of $22.85 billion. Johnson & Johnson had a net margin of 25.00% and a return on equity of 32.49%. The business's quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $2.82 earnings per share. On average, analysts forecast that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 26th will be paid a $1.30 dividend. The ex-dividend date is Tuesday, August 26th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 3.0%. Johnson & Johnson's dividend payout ratio is presently 55.61%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.